TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05162690

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10 milligram
Description: 10mg per day of Dapagliflozin will be given to the patients

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Metformin DPP4 inhibitors
Study: NCT06134817

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Embozene Color-Advanced Microspheres.
Description: Embozene Microspheres are spherical, tightly calibrated, biocompatible, nonresorbable, hydrogel microspheres coated with an inorganic perfluorinated polymer. The microspheres are intended to occlude vasculature for the purpose of blocking blood flow to a target tissue.~In the study, the abnormal vessels will be embolized with 100 μm Embozene Microspheres solution under direct fluoroscopic visualization to prevent reflux and non-target embolization. Multiple geniculate arteries may be embolized until neovascularity is no longer seen.
Study: NCT06372795

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pure effortful swallowing
Description: The investigator instructed the patient to swallow forcefully while squeezing the tongue upward and backward in the direction of the soft palate based on the sounds of an electronic timer.
Study: NCT06006949

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roxadustat
Description: Roxadustat (150 mgqod)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luspatercept
Description: Luspatercept (1.0 mg/kg, subcutaneously injection every 3 weeks, adjusted according to blood pattern, up to 1.75mg/kg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luspatercept
Description: Luspatercept (1.0 mg/kg, subcutaneously injection every 3 weeks, adjusted according to blood pattern, up to 1.75mg/kg)
Study: NCT06372795

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: progressive resistance swallowing training
Description: Patients in the test group, resistance swallowing exercise was performed by providing external resistance through Iowa Oral Performance Instrument (IOPI), and all other protocols were performed the same as those in the control group.
Study: NCT05529472

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peripheral Orbital Atherectomy System (OAS)
Description: Treatment with Orbital Atherectomy System (OAS) followed by Percutaneous Old Balloon Angioplasty (POBA), pre-dilation and Drug Coated Balloon (DCB) - Medtronic IN.PACT™ Admiral™
Study: NCT05364996

Intervention type: DIAGNOSTIC_TEST
Intervention: bronchial endoscopy with bronchoalveolar lavage (LBA)
Description: Bronchial endoscopy under laryngeal mask and general anesthesia. BAL of saline at room temperature of 3 milliliters per kilogram limited to 20 milliliters x 3 according to recommendations

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling
Description: collection of 5 milliliters of blood for total white cells count, C-Reactive Protein, specific immunoglobulin E assays, serum sRAGE assay
Study: NCT06411587

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound imaging and functional assessment
Description: Participants in this study will undergo two types of assessments: capturing muscle images using ultrasound and evaluating their function through clinical scales.

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound imaging and functional assessment
Description: Participants in this study will undergo two types of assessments: capturing muscle images using ultrasound and evaluating their function through clinical scales.
Study: NCT06015477

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Description: starting dose of ticagrelor was a single loading dose of 180mg (90mg x 2 tablets) and thereafter 1 tablet (90mg) each time, twice daily.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dual Antiplatelet Therapy
Description: Clopidogrel 75mg + Aspirin 100mg 1 month, after 1 month, change to aspirin 100mg 1 year.
Study: NCT05211999

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Precede-Proceed Model Based Simulation Experience
Description: The program was created on the basis of the PRECEDE-PROCEED Model.The program consists of eight phases. It will be carried out with theoretical training and simulation experience in the experimental group. In the control group, theoretical training will be given. Results will be followed.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control Group
Description: No intervention in control group just theoretical education was done for them.
Study: NCT06141941

Intervention type: DEVICE
Group type: OTHER
Intervention: CGM
Description: Continuous glucose monitoring
Study: NCT05431049

Intervention type: PROCEDURE
Intervention: Percutaneous nephrolithotomy surgery (PNL)
Description: Percutaneous nephrolithotomy (PNL) surgery was performed in all arms of the study to remove the renal stones. This surgery was performed with 2 anesthesia methods, CSEA and GA. These formed the groups of the study.

Intervention type: PROCEDURE
Intervention: Percutaneous nephrolithotomy surgery (PNL)
Description: Percutaneous nephrolithotomy (PNL) surgery was performed in all arms of the study to remove the renal stones. This surgery was performed with 2 anesthesia methods, CSEA and GA. These formed the groups of the study.
Study: NCT06101758

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Handgrip strength test
Description: A handgrip strength test using a hydraulic hand dynamometer will be performed

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: total body Dual Energy X-Ray Absorptiometry (DXA)
Description: A total body Dual Energy X-Ray Absorptiometry (DXA) to estimate muscle mass will be performed

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Muscle ultrasound
Description: A muscular ultrasound of abdominal muscles, forearm muscles, quadriceps and gastrocnemius will be performed
Study: NCT04937725

Intervention type: DIAGNOSTIC_TEST
Intervention: eye tracking
Description: Eye tracker will be used to evaluate study parameters

Intervention type: DIAGNOSTIC_TEST
Intervention: eye tracking
Description: Eye tracker will be used to evaluate study parameters
Study: NCT06086743

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: This group will perform 10 minutes of same warm up exercises. After warm up participants will perform 4 resistance exercises with induced EMS. The assessment of muscle strength, muscle bulk and muscle fat of the participants will be carried out at baseline before resistance exercises. the intensity of EMS would be 100A and it would remain same throughout training session. The current administered would be galvanic current. Initially the weight will be adjusted according to 1 repetition maximum, and it will increase 2kg after 3 week. 3 sets of every exercise would be performed; every set will have 12 repetitions. These exercises will be performed 3 days a week for 6 weeks. Readings of both the groups will be taken at baseline and at the end of last week.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Group B (Control group)will perform 10 minutes of same warm up exercises (Arm swings, jogging on the spot, Walks on treadmill). Group B will perform same 4 resistance exercises without EMS. These 4 exercises include Bicep curls, Triceps dips, Quadriceps chair and squats.The assessment of muscle strength, muscle bulk and muscle fat of the participants will be carried out at baseline before resistance exercises and the participants will be instructed, not to perform any kind of exercise during this period.Initially the weight will be adjusted according to 1 repetition maximum, and it will increase 2kg after 3 week. 3 sets of every exercise would be performed; every set will have 12 repetitions. These exercises will be performed 3 days a week for 6 weeks. Readings of both the groups will be taken at baseline and at the end of last week.
Study: NCT04772209

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium bicarbonate
Description: Dialysis catheter lumen will be filled (locked) by sodium bicarbonate solution. The amount of solution depends on the diameter and length and will be in accordance with the manufacturer's specifications.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Heparin
Description: Dialysis catheter lumen will be filled (locked) by classic heparin. The amount of pure heparin depends on the diameter and length and will be in accordance with the manufacturer's specifications.
Study: NCT06435637

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Collagen protein
Description: Ingestion of 40, 20, 20 and 20 gram of collagen protein right after and every 2 hours after a bout of exercise
Study: NCT04533815

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LOCK sleep intervention
Description: Nursing home staff are trained to use a collaborative problem-solving approach to sleep quality improvement using front-line huddling
Study: NCT05009030

Intervention type: DRUG
Intervention: COVID-19 vaccine
Description: Lung cancer patients will receive an anti-COVID19 vaccine approved by the European Medicines Agency according to the guidelines approved by the regulatory authorities
Study: NCT04656418

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSL312
Description: Fully human immunoglobulin G subclass 4/lambda recombinant monoclonal antibody

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Buffer without active ingredient
Study: NCT06435637

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: A single resistance exercise session of the leg press and leg extension exercise

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Resistance exercise
Description: A single resistance exercise session of the leg press and leg extension exercise
Study: NCT04853706

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: 3d cam
Description: The 3D-CAM is a short interview that uses verbal responses and allows completion of the Confusion Assessment Method (CAM) diagnostic algorithm

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: DSM 5
Description: The DSM-5 is the gold standard for diagnosing delirium. But proper use requires professional psychiatric background and training.
Study: NCT04987021

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cochlear Implant (CI)-CI500 series, CI600 series or Freedom series cochlear implants
Description: The Remote Assist (RA) System is intended to support clinicians to conduct a remote programming session with their CI recipients.
Study: NCT05284565

Intervention type: DEVICE
Group type: OTHER
Intervention: Reading of the skin prick allergy test
Description: A double reading of the forearm will be performed with the Nexkin DSPT device. Also, two healthcare professionals will perform, consecutively, the manual reading according to their usual practice. Nexkin DSPT device provides a semi-automatic wheal detection, presenting the user an initial set of potential wheals and information about them (as their measure).~Healthcare professional can then discard, add and/or confirm wheals by visual validation, and add/edit wheal information. The device automates the test reading process, digitises the results, and quantifies.
Study: NCT05938426

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ET-101
Description: Patients have training sessions twice a day. Each training session takes about 10\~25 minutes. Cognitive training programs include meditation, cognitive training, and cognitive testing.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Device
Description: Sham device has only cognitive function test excluding training programs.
Study: NCT04913415

Intervention type: OTHER
Group type: OTHER
Intervention: Low Suction Strategy of Chest Tube Management
Description: A digital chest tube will be set to a low pressure mode (-8mmHg) during recovery after minimally invasive lung resection.

Intervention type: OTHER
Group type: OTHER
Intervention: Standard Suction Strategy of Chest Tube Management
Description: A digital chest tube will be to the standard suction mode (-20mmHg) during recovery after minimally invasive lung resection.
Study: NCT05708937

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness based phone app
Description: Creating mindfulness-based suggestions for infertile women:~Mindfulness-based content was created by taking the opinions of experts in the fields of women's health nursing, psychology and linguistics. It consists of 6 different parts. The content of meditation that the patient will apply according to the treatment stage is different. Infertility mindfulness departments; Breath Awareness, Body \& Uterus Awareness, Needle Therapy and Ovarian Awareness, Pre-Egg Collection (OPU) Diaphragm Breathing, Pre-embryo Transfer Uterine Awareness, Embryo and Uterine Awareness (Post transfer).~Audio recordings of mindfulness-themed meditation content:~After the meditation contents are planned; the sound recording was taken with a professional recorder (Sony ICD-PX470). The audio recordings taken were professionally edited by the expert. Mp3 recordings were created by adding background music to sound recordings in computer environment. Audio recordings of mindfulness-themed meditation content
Study: NCT05989542

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLB1001
Description: 200mg BID Oral
Study: NCT05293574

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: norethisterone acetate
Description: Norethindrone, a progesterone agonist
Study: NCT05753098

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: estrogen therapy
Description: oral estradiol valerate

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sildenafil
Description: PDE5 inhibitor

Intervention type: DRUG
Group type: OTHER
Intervention: Clomiphene Citrate 50mg
Description: used for ovulation induction

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphene Citrate 50mg
Description: used for ovulation induction

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphene Citrate 50mg
Description: used for ovulation induction
Study: NCT05480826

Intervention type: GENETIC
Group type: OTHER
Intervention: study of the transmission of genetic variants
Description: the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA

Intervention type: GENETIC
Group type: OTHER
Intervention: study of the transmission of genetic variants
Description: the genetic variants of interest will be investigated by sequencing or genotyping on genomic DNA
Study: NCT05557734

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: caudal block
Description: injection of local anesthestic through the scral hiatus into the sacral canal to reach caudal epidural space

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: perianal block
Description: local anesthestic infiltration in the perianal area to block terminal branches of the nerves supplying the anal canal
Study: NCT06414239

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of a VR mask
Description: Virtual reality mask

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care
Description: Without any premedication or anesthesia
Study: NCT04929938

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Description: This is a combination of cognitive-behavioural techniques oriented to improve the emotional regulation. The Unified Protocol is comprised of 8 modules and it is applied following The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders Manual (Barlow, 2017).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Description: This is a combination of cognitive-behavioural techniques oriented to improve the emotional regulation. The Unified Protocol is comprised of 8 modules and it is applied following The Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders Manual (Barlow, 2017).
Study: NCT05215080

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Organic Formula Milk
Description: Organic formula milk is given to the infants three times a day for three months. Each serving contains 7 spoons (1 spoon contain 4,6 grams) of milk powder and 210 ml of water.
Study: NCT05322278

Intervention type: OTHER
Intervention: Data collection
Description: No interventions
Study: NCT05321940

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
Description: Autologous human ultraviolet (UV)-irradiated (dead) leukemia cells loaded with STAVs administered via intravenous injection. Each treatment will administer 5 ml via syringe.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dendritic Cell Vaccine
Description: 15-20 Million mature dendritic cells per dose administered via intravenous injection.
Study: NCT04880850

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin icodec
Description: Participants will receive subcutaneous (s.c.) injections of insulin icodec once weekly for 26 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin glargine
Description: Participants will receive subcutaneous (s.c.) injections of insulin glargine once daily for 26 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin aspart
Description: Participants will receive subcutaneous (s.c.) injections of insulin aspart 2-4 times daily for 26 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin aspart
Description: Participants will receive subcutaneous (s.c.) injections of insulin aspart 2-4 times daily for 26 weeks
Study: NCT05937217

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: myofascial induction and direct scar release techniques
Description: Manual therapy techniques used to reduce chronic lower transverse abdominal scars pain and improve quality of life of the affected women

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: therapeutic ultrasound
Description: Ultrasound petron (model SM 500) specifications: output frequency:1Mhz, output power:5W/cm², power intensity:5 degree (0.8-1.2-1.6-2.0-2.5), time intensity:5-30(step by 5 min) . It will be applied for both groups for 10 minutes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: therapeutic ultrasound
Description: Ultrasound petron (model SM 500) specifications: output frequency:1Mhz, output power:5W/cm², power intensity:5 degree (0.8-1.2-1.6-2.0-2.5), time intensity:5-30(step by 5 min) . It will be applied for both groups for 10 minutes
Study: NCT05928637

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D745, D759, D150
Description: QD, PO for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D745, D759, D150
Description: QD, PO for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D745, D759, D150
Description: QD, PO for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D745, D759, D150
Description: QD, PO for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D745, D759, D150
Description: QD, PO for 5 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D745, D759, D150
Description: QD, PO for 5 days
Study: NCT02686203

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: B-Cure Laser Pro and needles
Description: Treatment will consist of acupuncture applied by a combination of B-Cure Laser Pro, an approved handheld, portable device emitting low level laser, and needles using two to four acupoints (The Investigational Therapy).~The Investigational Therapy will be administered by a treating therapist designated by the Sponsor who is experienced in employing the treatment
Study: NCT06394674

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Drug: Furmonertinib

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Drug: Furmonertinib
Study: NCT04511052

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Daily intake of 10 x 10\^9 CFU of a proprietary strain for a total duration of 10 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 capsule daily containing the same carrier material that is similar in size, shape and taste to the probiotic, for a duration of 10 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Carotenoid supplement
Description: 1 capsule daily containing \~20 mg of total carotenoids for a total duration of 10 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Carotenoid supplement
Description: 1 capsule daily containing \~20 mg of total carotenoids for a total duration of 10 weeks
Study: NCT04686838

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: READyR II: A
Description: Continuous monitoring for anomaly detection and contact phone call when a potential change in care needs is indicated by an anomaly.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: READyR II: B
Description: Sensors will remain in the home but anomaly detection analysis will not be performed and contact phone calls will be at regular intervals without dynamic tailoring content.
Study: NCT04901013

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Affinity
Description: Affinity is an aseptically processed, hypothermically stored fresh allograft with viable cells, growth factors/cytokines, and extracellular matrix (ECM).
Study: NCT05665920

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Ultra-hypofractionated whole breast radiotherapy
Description: Ultra-hypofractionated whole breast radiotherapy, 26 Gray (26Gy) in 5 fractions for one week

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Standard Radiation
Description: Standard Radiation: Whole Breast Irradiation, at 40 Gy, in 15 fractions and drainage